Annual Total Expenses
$137.64 M
+$23.13 M+20.20%
December 31, 2024
Summary
- As of March 13, 2025, TCRX annual total expenses is $137.64 million, with the most recent change of +$23.13 million (+20.20%) on December 31, 2024.
- During the last 3 years, TCRX annual total expenses has risen by +$78.86 million (+134.15%).
- TCRX annual total expenses is now at all-time high.
Performance
TCRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$37.38 M
+$3.71 M+11.01%
December 31, 2024
Summary
- As of March 13, 2025, TCRX quarterly total expenses is $37.38 million, with the most recent change of +$3.71 million (+11.01%) on December 31, 2024.
- Over the past year, TCRX quarterly total expenses has stayed the same.
- TCRX quarterly total expenses is now at all-time high.
Performance
TCRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TCRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.2% | 0.0% |
| 3 y3 years | +134.2% | +30.5% |
| 5 y5 years | +868.6% | +30.5% |
TCRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.2% | at high | +119.1% |
| 5 y | 5-year | at high | +868.6% | at high | +565.5% |
| alltime | all time | at high | +868.6% | at high | +565.5% |
TScan Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $137.64 M(+20.2%) | $37.38 M(+11.0%) |
| Sep 2024 | - | $33.67 M(-2.8%) |
| Jun 2024 | - | $34.65 M(+8.5%) |
| Mar 2024 | - | $31.94 M(+11.8%) |
| Dec 2023 | $114.51 M(+42.8%) | $28.57 M(-0.2%) |
| Sep 2023 | - | $28.64 M(+3.2%) |
| Jun 2023 | - | $27.76 M(-6.1%) |
| Mar 2023 | - | $29.55 M(+35.9%) |
| Dec 2022 | $80.17 M | $21.74 M(+9.0%) |
| Sep 2022 | - | $19.94 M(+3.3%) |
| Jun 2022 | - | $19.30 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.18 M(+12.5%) |
| Dec 2021 | $58.78 M(+115.2%) | $17.06 M(-6.6%) |
| Sep 2021 | - | $18.25 M(+34.9%) |
| Jun 2021 | - | $13.53 M(+36.0%) |
| Mar 2021 | - | $9.95 M(+15.6%) |
| Dec 2020 | $27.32 M(+92.2%) | - |
| Dec 2020 | - | $8.61 M(+15.3%) |
| Sep 2020 | - | $7.46 M(+32.9%) |
| Jun 2020 | - | $5.62 M(-0.4%) |
| Mar 2020 | - | $5.64 M |
| Dec 2019 | $14.21 M | - |
FAQ
- What is TScan Therapeutics annual total expenses?
- What is the all time high annual total expenses for TScan Therapeutics?
- What is TScan Therapeutics annual total expenses year-on-year change?
- What is TScan Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for TScan Therapeutics?
- What is TScan Therapeutics quarterly total expenses year-on-year change?
What is TScan Therapeutics annual total expenses?
The current annual total expenses of TCRX is $137.64 M
What is the all time high annual total expenses for TScan Therapeutics?
TScan Therapeutics all-time high annual total expenses is $137.64 M
What is TScan Therapeutics annual total expenses year-on-year change?
Over the past year, TCRX annual total expenses has changed by +$23.13 M (+20.20%)
What is TScan Therapeutics quarterly total expenses?
The current quarterly total expenses of TCRX is $37.38 M
What is the all time high quarterly total expenses for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total expenses is $37.38 M
What is TScan Therapeutics quarterly total expenses year-on-year change?
Over the past year, TCRX quarterly total expenses has changed by $0.00 (0.00%)